Effect of macitentan on haemodynamics in patients with pulmonary arterial hypertension: results from the long-term, randomised, placebo-controlled SERAPHIN trial

被引：0
|
作者：
Torbicki, A. [1 ]
Mehta, S. [2 ]
Perchenet, L. [3 ]
Pulido, T. [4 ]
Sastry, B. K. S. [5 ]
Sitbon, O. [6 ]
Souza, R. [7 ]
Rubin, L. J. [8 ]
Simonneau, G. [6 ]
机构：
[1] Ctr Postgrad Med Educ, Ecz Otwock, Poland
[2] London Hlth Sci Ctr, London, ON, Canada
[3] Actel Pharmaceut Ltd, Allschwil, Switzerland
[4] Natl Inst Cardiol Ignacio Chavez, Mexico City, DF, Mexico
[5] CARE Hosp, Hyderabad, Andhra Pradesh, India
[6] Hop Univ Bicetre, Serv Pneumol, Paris, France
[7] Univ Sao Paulo, Sch Med, Inst Heart, Sao Paulo, Brazil
[8] Univ Calif San Diego, San Diego, CA 92103 USA
来源：
EUROPEAN HEART JOURNAL | 2013年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：186 / 186
页数：1
相关论文
共 50 条
  • [31] Adjusting Overall Survival Estimates of Macitentan in Pulmonary Arterial Hypertension After Treatment Switching: Results from the SERAPHIN Study
    Di Scala, Lilla
    Bacchi, Marisa
    Bayer, Bjorn
    Turricchia, Stefano
    ADVANCES IN THERAPY, 2022, 39 (09) : 4346 - 4358
  • [32] Effect of Macitentan on Long-term Outcomes in Patients With Pulmonary Arterial Hypertension (PAH): Subanalysis of SERAPHIN Comparing Incident and Prevalent Patient Populations Not Treated With Background PAH-Specific Therapy
    Simonneau, Gerald
    Channick, Richard
    Delcroix, Marion
    Galie, Nazzareno
    Ghofrani, Hossein
    Jansa, Pavel
    Le Brun, Franck-Olivier
    Mehta, Sanjay
    Perchenet, Loic
    Pulido, Tomas
    Sastry, B.
    Sitbon, Olivier
    Souza, Rogerio
    Torbicki, Adam
    Rubin, Lewis
    CHEST, 2013, 144 (04)
  • [33] Association between six-minute walk distance and long-term outcomes in patients with pulmonary arterial hypertension: Data from the randomized SERAPHIN trial
    Souza, Rogerio
    Channick, Richard N.
    Delcroix, Marion
    Galie, Nazzareno
    Ghofrani, Hossein-Ardeschir
    Jansa, Pavel
    Le Brun, Franck-Olivier
    Mehta, Sanjay
    Perchenet, Loic
    Pulido, Tomas
    Sastry, B. K. S.
    Sitbon, Olivier
    Torbicki, Adam
    Rubin, Lewis J.
    Simonneau, Gerald
    PLOS ONE, 2018, 13 (03):
  • [34] Long-term effect of pulmonary rehabilitation in idiopathic pulmonary fibrosis: a randomised controlled trial
    Kataoka, Kensuke
    Nishiyama, Osamu
    Ogura, Takashi
    Mori, Yoshihiro
    Kozu, Ryo
    Arizono, Shinichi
    Tsuda, Tohru
    Tomioka, Hiromi
    Tomii, Keisuke
    Sakamoto, Koji
    Ishimoto, Hiroshi
    Kagajo, Michiko
    Ito, Hiroyuki
    Ichikado, Kazuya
    Sasano, Hajime
    Eda, Seiichirou
    Arita, Machiko
    Goto, Yasuhiro
    Hataji, Osamu
    Fuke, Satoshi
    Shintani, Ryota
    Hasegawa, Hirotsugu
    Ando, Masahiko
    Ogawa, Tomoya
    Shiraishi, Masashi
    Watanabe, Fumiko
    Nishimura, Koichi
    Sasaki, Takuma
    Miyazaki, Shinjiro
    Saka, Hideo
    Kondoh, Yasuhiro
    THORAX, 2023, 78 (08) : 784 - 791
  • [35] The efficacy and safety of macitentan in Fontan-palliated patients: results of the 52-week randomised, placebo-controlled RUBATO trial
    Clift, P.
    Berger, F.
    Sondergaard, L.
    Antonova, P.
    Disney, P.
    Nicolarsen, J.
    Thambo, J. -B.
    Pajak, L. Tomkiewicz
    Wang, J. -K.
    Jensen, A. Schophuus
    Burgess, G.
    Efficace, M.
    Friberg, M.
    Lassen, C.
    d'Udekem, Y.
    EUROPEAN HEART JOURNAL, 2022, 43 : 1560 - 1560
  • [36] Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial
    Reginster, JY
    Deroisy, R
    Rovati, LC
    Lee, RL
    Lejeune, E
    Bruyere, O
    Giacovelli, G
    Henrotin, Y
    Dacre, JE
    Gossett, C
    LANCET, 2001, 357 (9252): : 251 - 256
  • [37] Discontinuing long-term antisecretory treatment a randomised, blinded, placebo-controlled trial in primary care
    Zwisler, J. E.
    Lassen, A. T.
    Pedersen, N. T.
    Jarbol, D. E.
    Kragstrup, J.
    de Muckadell, O. B. Schaffalitzky
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2007, 42 : 24 - 24
  • [38] SUSTAINED EFFECT OF MACITENTAN ON EXERCISE CAPACITY AND THE ASSOCIATION OF ITS MEASURE WITH LONG-TERM OUTCOMES IN PULMONARY ARTERIAL HYPERTENSION
    Whitford, H.
    Galie, N.
    Souza, R.
    Perchenet, L.
    Rubin, L.
    Simonneau, G.
    RESPIROLOGY, 2014, 19 : 29 - 29
  • [39] Early selexipag initiation and long-term outcomes: insights from randomised controlled trials in pulmonary arterial hypertension
    Coghlan, J. Gerry
    Gaine, Sean
    Channick, Richard
    Chin, Kelly M.
    du Roure, Camille
    Gibbs, J. Simon R.
    Hoeper, Marius M.
    Lang, Irene M.
    Mathai, Stephen C.
    McLaughlin, Vallerie V.
    Mitchell, Lada
    Simonneau, Gerald
    Sitbon, Olivier
    Tapson, Victor F.
    Galie, Nazzareno
    ERJ OPEN RESEARCH, 2023, 9 (01)
  • [40] Long-term trial of bosentan monotherapy for pulmonary arterial hypertension in Japanese patients
    Sasayama, Shigetake
    Satoh, Toru
    Izumi, Tohru
    Yoshida, Shunji
    Kyotani, Shingo
    Tahara, Nobuhiro
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (02) : 395 - 400
12345